Zeolitic imidazolate framework‐67–modified open‐tubular column with cyclodextrin for enantioseparation in capillary electrochromatography

Abstract The histidine‐modified zeolitic imidazolate framework [His‐ZIF‐67] was prepared with the histidine, 2‐methylimidazole, and Co 2+ under ambient temperature. His‐ZIF‐67 was bonded via a glycidyl methacrylate copolymer to the internal surface of capillary and then functionalized with the NH 2 ‐β‐cyclodextrin (NH 2 ‐β‐CD). The materials were characterized by field emission scanning electron microscopy, high‐resolution transmission electron microscopy, thermogravimetric analysis, Fourier transform infrared spectroscopy, N 2 adsorption–desorption isotherm, X‐ray diffraction, and X‐ray photoelectron spectroscopy. In comparison with the NH 2 ‐β‐CD@capillary, the NH 2 ‐β‐CD@His‐ZIF‐67@capillary‐coated column shows significantly enhanced resolution for chiral molecules. The NH 2 ‐β‐CD@His‐ZIF‐67@capillary column achieved the baseline separation of amlodipine and metoprolol (the resolution of amlodipine: 1.70; metoprolol: 1.50) and the partial separation of atenolol and propranolol (the resolution of atenolol: 1.03; propranolol: 0.60). These were attributed to the histidine modification and the features of ZIF‐67, including an excellent surface area and the abundant porosity. The pH and proportion of organic modifier in the buffer were crucial for enantioseparation performance and were evaluated in detail. The fabricated NH 2 ‐β‐CD@His‐ZIF‐67@capillary‐coated column showed good stability and repeatability (relative standard deviation <6.3%). The molecular modeling with AutoDock and grand canonical ensemble was carried out to evaluate the interactions between chiral stationary phase and racemic drugs.